The global COVID-19 pandemic has presented significant challenges for healthcare
professionals, including specialists in inflammatory bowel disease (IBD), in managing
the specific clinical needs of their patients. This article provides
a summary of the current literature regarding the management of
IBD patients during the COVID-19 pandemic, which has informed the
reorganization of our IBD unit and the clinical recommendations offered
to our patients.